Metabolic improvementsincluded a reduction in insulin levels (from 67.25 ± 47.58 to 39.66 ±21.11 pmol/L, p = 0.033) and insulin resistance (from 2.19 ± 1.57to 1.25 ± 0.69, p = 0.029), while fasting glucose levels remainedstable. Here, INS is linked to Insulin resistance.